Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrism
SAN FRANCISCO, Oct. 02, 2018 (GLOBE NEWSWIRE) — Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today that its laboratory has successfully [...]